Picture of Nexxen International logo

NEXN Nexxen International News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeSmall CapSuper Stock

REG - Nexxen International - Q3 & 9-Month 2024 Results

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241115:nRSO3415Ma&default-theme=true

RNS Number : 3415M  Nexxen International Ltd  15 November 2024

 15 November 2024

Nexxen International Ltd

("Nexxen" or the "Company")

 

 Nexxen Reports Third Quarter 2024 Financial Results

 

Generated 12% year-over-year Contribution ex-TAC growth in Q3 2024, fueled by
record Q3 CTV revenue which increased 52% year-over-year

 

Achieved 49% year-over-year Adjusted EBITDA growth in Q3 2024 while expanding
Adjusted EBITDA Margin as a percentage of Contribution ex-TAC to 37% from 28%
in Q3 2023

 

Reaffirming full year 2024 Contribution ex-TAC guidance and raising full year
2024 Adjusted EBITDA guidance

 

Nexxen International Ltd. (AIM/NASDAQ: NEXN) ("Nexxen" or the "Company"), a
global, flexible advertising technology platform with deep expertise in data
and advanced TV, announced today its financial results for the three and nine
months ended September 30, 2024.

 

Q3 2024 Financial Highlights

 

·    Record Q3 Contribution ex-TAC of $85.5 million, up 12% year-over-year

·    Record Q3 programmatic revenue of $81.6 million, up 10%
year-over-year

·    Record Q3 CTV revenue of $29.7 million, up 52% year-over-year

·    CTV revenue reflected 36% of programmatic revenue, up from 26% in Q3
2023

·    Programmatic revenue reflected 90% of revenue, compared to 93% in Q3
2023

·    Adjusted EBITDA of $31.6 million, up 49% year-over-year, representing
a 37% Adjusted EBITDA Margin on a Contribution ex-TAC basis (35% on a revenue
basis), compared to 28% (27% on a revenue basis) in Q3 2023

·    Video revenue reflected 71% of programmatic revenue, up from 66% in
Q3 2023

·    $166.5 million net cash as of September 30, 2024, alongside $90
million undrawn on the Company's revolving credit facility and no long-term
debt

 

Financial Highlights for the Nine Months Ended September 30, 2024

 

·    Record Contribution ex-TAC of $238.3 million, up 7% year-over-year

·    Record programmatic revenue of $225.7 million, up 6% year-over-year

·    Record CTV revenue of $76.7 million, up 17% year-over-year

·    CTV revenue reflected 34% of programmatic revenue, compared to 31%
for the same prior year period

·    Programmatic revenue reflected 89% of revenue, compared to 90% for
the same prior year period

·    Adjusted EBITDA of $70.3 million, up 37% year-over-year, representing
a 29% Adjusted EBITDA Margin on a Contribution ex-TAC basis (28% on a revenue
basis), compared to 23% (22% on a revenue basis) for the same prior year
period

·    Video revenue reflected 70% of programmatic revenue for the nine
months ended September 30, 2024 and 2023

 

"Nexxen continues to execute on its strategy as our platform's powerful and
fully integrated data, CTV and video capabilities offer much-needed AdTech
solutions for advertisers and digital publishers. Over the last several
quarters we've clarified our value proposition while improving our sales
efforts and operational efficiency, which together drove record Q3 results,"
said Ofer Druker, Chief Executive Officer of Nexxen. "Major players in the
industry are increasingly partnering with Nexxen for a combination of its
robust technology and data capabilities, flexible unified platform approach
and ability to maximize efficiency and returns across the AdTech and data
supply chain. Looking ahead, we strongly believe our full stack platform and
robust access to data gives Nexxen an AI edge, and that our Generative AI
initiative will contribute to Nexxen's growth, as well as its platform
differentiation and appeal in 2025 by further enhancing usability and outcomes
for our customers."

 

Financial Guidance

 

o  Nexxen provides the following financial guidance for full year 2024:

 

·      Reaffirming full year 2024 Contribution ex-TAC in a range of
approximately $340 - $345 million

·   Raising full year 2024 Adjusted EBITDA to approximately $107 million
from approximately $100 million

·   Reaffirming full year 2024 programmatic revenue to reflect
approximately 90% of full year 2024 revenue

 

o  Management expects the Company to increase its technology, data, AI and
Generative AI investments in Q4 2024 and full year 2025 to further its
platform and data advantages.

 

Operational Highlights

 

·    Launched strategic automatic content recognition ("ACR") data
partnership with The Trade Desk, expanding the Company's data licensing
revenue opportunities and sales channels.

 

·    Named a preferred data platform partner for Kinective Media by United
Airlines, enabling Nexxen's advertiser clients to tap into premium first party
data from United's customers and MileagePlus loyalty program members to layer
insights onto campaigns, and Tinuiti has been an early adopter.

 

·    Released data-driven solutions catered to political advertiser
clients which fueled increased audience reach and deeper campaign insights for
customers around the 2024 U.S. election cycle, while helping drive what the
Company believes will reflect record annual political Contribution ex-TAC for
Nexxen.

 

·    Added an all-time high 138 new actively-spending first-time
advertiser customers in Q3 2024 across travel, political and other verticals,
inclusive of 31 new enterprise self-service advertiser customers and two new
independent agencies leveraging the Company's self-service software solutions.

 

·    Onboarded 61 new supply partners across several verticals and formats
including CTV, mobile app, gaming, display, audio and online video in Q3 2024.

 

Share Repurchase Program Updates

 

o  Nexxen (and its subsidiaries) repurchased 5,089,680 Ordinary shares during
Q3 2024 at an average price of 275.87 pence, reflecting a total investment of
£14.1 million or $18.3 million.

o  From March 1, 2022, through September 30, 2024, the Company (and its
subsidiaries) repurchased 33,415,495 Ordinary shares, or 21.6% of shares
outstanding, reflecting a total investment of £110.2 million or $137.2
million.

o  The Company received approval to launch a new $50 million Ordinary Share
repurchase program which is expected to begin on November 19, 2024 and
continue until May 19, 2025 or completion. The impending program does not
obligate Nexxen to repurchase any particular amount of Ordinary Shares and the
program may be suspended, modified or discontinued at any time at the
Company's discretion (if not in a close period), subject to applicable law.
The Company's previous Ordinary Share repurchase program expired on November
1, 2024.

o  Nexxen's Board of Directors intends to continue evaluating the potential
for implementing additional share repurchase programs upon completion of the
impending program, subject to then current market conditions and necessary
approvals.

 

Annual General Meeting ("AGM") Update: Nexxen ADR to Ordinary Share Exchange,
Reverse Share Split and AIM Delisting to be Voted on by Shareholders

 

o  Nexxen's Board of Directors approved submission of several trading
structure changes to a shareholder vote at the Company's upcoming AGM taking
place on December 20, 2024. If approved by shareholders, the Company intends
to exchange its Nasdaq-listed ADRs to Nasdaq-listed Ordinary Shares and
terminate the ADR facility, conduct a reverse share split at a two-for-one
ratio which will allow for a one-to-one exchange for ADRs into Ordinary Shares
and delist from the AIM.

o  The Company and its Board of Directors believe this updated trading
structure can benefit Nexxen and its shareholders over the long term for
several reasons including increasing the potential to attract U.S. investors,
reducing the complexity of the Company's reporting and regulatory compliance
structure, consolidating and increasing liquidity, possible inclusion in major
indices which the Company's shares are precluded from due to its current
structure, better aligning the Company's stock with other U.S.-listed AdTech
companies, reducing price volatility that can result from a dual-listing and
cost savings.

o  The AGM circular provides greater detailed information on this proposal,
the timing of the proposed changes and its effect on trading for the Company's
U.S. and U.K. investors.

o  The Company intends to host calls with both U.S. and U.K. investors and
analysts ahead of the upcoming AGM to provide greater details on the proposed
changes, timing of those changes and its strategic rationale.

 

Change to Board of Directors

 

o  Nexxen announces that Executive Director Yaniv Carmi, a Director since
2014, is stepping down from the Company's Board of Directors ("Board")
effective November 15, 2024, thereby reducing the size of the Board from nine
members to eight members. Mr. Carmi will continue to serve as Nexxen's Chief
Operating Officer.

o  The Sustainability, Nominating and Governance Committee of the Board (the
"Committee") has determined that the smaller eight-member Board, consisting of
one Executive Director and seven Non-Executive Directors, will be more
flexible and efficient to support the ongoing needs of the business and that
the reduced Board size and composition is in line with Board composition
practices of similar sized companies traded on the Nasdaq and AIM.

o  The Committee further determined that Mr. Carmi stepping down from the
Board (but remaining Chief Operating Officer) is in line with best practices
of Nasdaq-listed companies similar to Nexxen, where the Chief Operating
Officer does not serve as a Director.

 

Financial Highlights for the Three and Nine Months Ended September 30, 2024 ($
in millions, except per share amounts)

                                                                   Three months ended September 30        Nine months ended September 30
                                                              2024              2023         %            2024      2023      %
 IFRS Highlights
 Revenue                                                      90.2              80.1         13%          253.2     236.1     7%
 Programmatic Revenue                                         81.6              74.2         10%          225.7     213.0     6%
 Operating profit (loss)                                      16.3              (3.4)        575%         16.1      (26.6)    160%

 Net income (loss) margin on a gross profit basis             23%               (2%)                      6%        (16%)

 Total comprehensive income (loss)                            16.5              (2.6)        743%         12.1      (23.5)    152%
 Diluted earnings (loss) per share                            0.10              (0.01)       1,341%       0.07      (0.17)    143%

 Non-IFRS Highlights
 Contribution ex-TAC                                          85.5              76.6         12%          238.3     223.7     7%

 Adjusted EBITDA                                              31.6              21.3         49%          70.3      51.2      37%
 Adjusted EBITDA Margin on a Contribution ex-TAC basis        37%               28%                       29%       23%

 Non-IFRS net income                                          19.1              13.4         42%          32.9      17.8      85%
 Non-IFRS diluted earnings per share                          0.14              0.09         48%          0.23      0.12      88%

 

Third Quarter 2024 Financial Results Webcast and Conference Call Details

 

·      When: November 15, 2024, at 6:00 AM PT / 9:00 AM ET / 2:00 PM GMT

·    Webcast: A live and archived webcast can be accessed from the Events
and Presentations section of Nexxen's Investor Relations website at
https://investors.nexxen.com/ (https://investors.nexxen.com/)

·    Participant Dial-In Numbers:

o  U.S. / Canada Toll-Free Dial-In Number: (888) 596-4144

o  U.K. Toll-Free Dial-In Number: +44 800 260 6470

o  International Dial-In Number: +1 (646) 968-2525

o  Conference ID: 8759727

 

About Nexxen

 

Nexxen empowers advertisers, agencies, publishers and broadcasters around the
world to utilize data and advanced TV in the ways that are most meaningful to
them. Our flexible and unified technology stack comprises a demand-side
platform ("DSP") and supply-side platform ("SSP"), with the Nexxen Data
Platform at its core. With streaming in our DNA, Nexxen's robust capabilities
span discovery, planning, activation, monetization, measurement and
optimization - available individually or in combination - all designed to
enable our partners to achieve their goals, no matter how far-reaching or
hyper niche they may be.

 

Nexxen is headquartered in Israel and maintains offices throughout the
United States, Canada, Europe and Asia-Pacific, and is traded on
the London Stock Exchange (AIM: NEXN) and NASDAQ (NEXN). For more
information, visit www.nexxen.com
(https://www.globenewswire.com/Tracker?data=8er6BEGEspzahjNz2HsjcYcQJCri9qzQfkLKJllLSndRki_wJpjNuBBrkiktBGxkYsjWJfLLyA-mvKewq03Jog==)

 

For further information please contact:

 

Nexxen International Ltd.

Billy Eckert, Vice President of Investor Relations
ir@nexxen.com (mailto:ir@nexxen.com)

 

Caroline Smith, Vice President of Communications

csmith@nexxen.com (mailto:csmith@nexxen.com)

 

Vigo Consulting (U.K. Financial PR & Investor Relations)

Jeremy Garcia / Peter Jacob

Tel: +44 20 7390 0230 or nexxen@vigoconsulting.com
(mailto:nexxen@vigoconsulting.com)

 

Cavendish Capital Markets Limited

Jonny Franklin-Adams / Seamus Fricker / Rory Sale (Corporate Finance)

Tim Redfern / Jamie Anderson (ECM)

Tel: +44 20 7220 0500

 

Forward Looking Statements

 

This press release contains forward-looking statements, including
forward-looking statements within the meaning of Section 27A of the United
States Securities Act of 1933, as amended, and Section 21E of the United
States Securities and Exchange Act of 1934, as amended. Forward-looking
statements are identified by words such as "anticipates," "believes,"
"expects," "intends," "may," "can," "will," "estimates," and other similar
expressions. However, these words are not the only way Nexxen identifies
forward-looking statements. All statements contained in this press release
that do not relate to matters of historical fact should be considered
forward-looking statements, including without limitation statements regarding
anticipated financial results for full year 2024, full year 2025 and beyond;
anticipated benefits of Nexxen's strategic transactions and commercial
partnerships; anticipated features and benefits of Nexxen's products and
service offerings; Nexxen's positioning for accelerated growth and continued
future growth in both the U.S. and international markets in 2024 and beyond;
Nexxen's medium- to long-term prospects; management's belief that Nexxen is
well-positioned to benefit from future industry growth trends and
Company-specific catalysts; the Company's expectations with respect to CTV
revenue growth and data licensing revenue growth; the Company's expectations
with respect to generating record annual political Contribution ex-TAC in full
year 2024; the Company's plans with respect to its cash reserves and future
share repurchase program; the anticipated impact of the Company's Generative
AI initiative and its ability to contribute to the Company's growth; the
anticipated benefits and potential timing of the Company's proposed ADR
exchange and termination, reverse split and AIM delisting; as well as any
other statements related to Nexxen's future financial results and operating
performance. These statements are neither promises nor guarantees but involve
known and unknown risks, uncertainties and other important factors that may
cause Nexxen's actual results, performance or achievements to be materially
different from its expectations expressed or implied by the forward-looking
statements, including, but not limited to, the following: negative global
economic conditions; global conflicts and war, including the war and
hostilities between Israel and Hamas, Hezbollah and Iran, and how those
conditions may adversely impact Nexxen's business, customers and the markets
in which Nexxen competes; changes in industry trends; the risk that Nexxen
will not realize the anticipated benefits of its acquisition of Amobee and
strategic investment in VIDAA; and, other negative developments in Nexxen's
business or unfavourable legislative or regulatory developments. Nexxen
cautions you not to place undue reliance on these forward-looking statements.
For a more detailed discussion of these factors, and other factors that could
cause actual results to vary materially, interested parties should review the
risk factors listed in the Company's most recent Annual Report on Form 20-F,
filed with the U.S. Securities and Exchange Commission (www.sec.gov
(https://www.globenewswire.com/Tracker?data=gPgQB1DRd3uO04Pe1Nw8HIpq46d0Dt1v2Oxk6rZfSqGQFu9JJd9FAB5SQGpGWUSLBV6GTasGV0uIK2SWvdiElw==)
) on March 6, 2024. Any forward-looking statements made by Nexxen in this
press release speak only as of the date of this press release, and Nexxen does
not intend to update these forward-looking statements after the date of this
press release, except as required by law.

 

Nexxen, and the Nexxen logo are trademarks of Nexxen International
Ltd. in the United States and other countries. All other trademarks are the
property of their respective owners. The use of the word "partner" or
"partnership" in this press release does not mean a legal partner or legal
partnership.

 

Use of Non-IFRS Financial Information

 

In addition to our IFRS results, we review certain non-IFRS financial measures
to help us evaluate our business, measure our performance, identify trends
affecting our business, establish budgets, measure the effectiveness of
investments in our technology and development and sales and marketing, and
assess our operational efficiencies. These non-IFRS measures include
Contribution ex-TAC, Adjusted EBITDA, Adjusted EBITDA Margin, Non-IFRS Net
Income and Non-IFRS Earnings per share, each of which is discussed below.

 

These non-IFRS financial measures are not intended to be considered in
isolation from, as substitutes for, or as superior to the corresponding
financial measures prepared in accordance with IFRS. You are encouraged to
evaluate these adjustments and review the reconciliation of these non-IFRS
financial measures to their most comparable IFRS measures and the reasons we
consider them appropriate. It is important to note that the particular items
we exclude from, or include in, our non-IFRS financial measures may differ
from the items excluded from, or included in, similar non-IFRS financial
measures used by other companies. See "Reconciliation of Revenue to
Contribution ex-TAC," "Reconciliation of Total Comprehensive Income (Loss) to
Adjusted EBITDA," and "Reconciliation of Net Income (Loss) to Non-IFRS Net
Income," included as part of this press release.

 

o Contribution ex-TAC: Contribution ex-TAC for Nexxen is defined as gross
profit plus depreciation and amortization attributable to cost of revenue and
cost of revenue (exclusive of depreciation and amortization) minus the
Performance media cost ("traffic acquisition costs" or "TAC"). Performance
media cost represents the costs of purchases of impressions from publishers on
a cost-per-thousand impression basis in our non-core Performance activities.
Contribution ex-TAC is a supplemental measure of our financial performance
that is not required by or presented in accordance with IFRS. Contribution
ex-TAC should not be considered as an alternative to gross profit as a measure
of financial performance. Contribution ex-TAC is a non-IFRS financial measure
and should not be viewed in isolation. We believe Contribution ex-TAC is a
useful measure in assessing the performance of Nexxen, because it facilitates
a consistent comparison against our core business without considering the
impact of traffic acquisition costs related to revenue reported on a gross
basis.

 

o Adjusted EBITDA: We define Adjusted EBITDA for Nexxen as total comprehensive
income (loss) for the period adjusted for foreign currency translation
differences for foreign operations, foreign currency translation for
subsidiary sold reclassified to profit and loss, financial expenses, net, tax
expenses (benefit), depreciation and amortization, stock-based compensation
expenses, acquisition related costs, restructuring and other expenses, net.
Adjusted EBITDA is included in the press release because it is a key metric
used by management and our Board of Directors to assess our financial
performance. Adjusted EBITDA is frequently used by analysts, investors and
other interested parties to evaluate companies in our industry. Management
believes that Adjusted EBITDA is an appropriate measure of operating
performance because it eliminates the impact of expenses that do not relate
directly to the performance of the underlying business.

 

o Adjusted EBITDA Margin: We define Adjusted EBITDA Margin as Adjusted EBITDA
on a Contribution ex-TAC basis.

 

o Non-IFRS Income and Non-IFRS Earnings per Share: We define non-IFRS earnings
per share as non-IFRS income divided by non-IFRS weighted-average shares
outstanding. Non-IFRS income is equal to net income (loss) excluding
acquisition related costs, stock-based compensation expenses, restructuring,
other expenses, net and amortization of acquired intangible assets, and also
considers the tax effects of non-IFRS adjustments. In periods in which we have
non-IFRS income, non-IFRS weighted-average shares outstanding used to
calculate non-IFRS earnings per share includes the impact of potentially
dilutive shares. Potentially dilutive shares consist of stock options,
restricted stock awards, restricted stock units and performance stock units,
each computed using the treasury stock method. We believe non-IFRS earnings
per share is useful to investors in evaluating our ongoing operational
performance and our trends on a per share basis and also facilitates
comparison of our financial results on a per share basis with other companies,
many of which present a similar non-IFRS measure. However, a potential
limitation of our use of non-IFRS earnings per share is that other companies
may define non-IFRS earnings per share differently, which may make comparison
difficult. This measure may also exclude expenses that may have a material
impact on our reported financial results. Non-IFRS earnings per share is a
performance measure and should not be used as a measure of liquidity. Because
of these limitations, we also consider the comparable IFRS measure of net
income.

 

We do not provide a reconciliation of forward-looking non-IFRS financial
metrics because reconciling information is not available without an
unreasonable effort, such as attempting to make assumptions that cannot
reasonably be made on a forward-looking basis to determine the corresponding
IFRS metric.

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 (as implemented into English law) ("MAR"). With the
publication of this announcement via a Regulatory Information Service, this
inside information is now considered to be in the public domain.

 

Reconciliation of Total Comprehensive Income (Loss) to Adjusted EBITDA

 

 

                                                                              Three months ended         Nine months ended

                                                                              September 30               September 30
                                                                              2024     2023     %        2024     2023      %
 ($ in thousands)
 Total comprehensive income (loss)                                            16,485   (2,563)  743%     12,123   (23,468)  152%
 Foreign currency translation differences for foreign operation               (1,944)  1,367             (1,540)  (12)
 Foreign currency translation for subsidiary sold reclassified to profit and  -        -                 -        (1,234)
 loss
 Tax expenses (benefit)                                                       1,503    (2,844)           3,628    (3,984)
 Financial expenses, net                                                      218      617               1,854    2,113
 Depreciation and amortization                                                12,758   20,316            44,055   57,238
 Stock-based compensation expenses                                            2,600    4,214             8,678    17,783
 Acquisition related costs                                                    -        171               -        171
 Restructuring                                                                -        -                 -        796
 Other expenses, net                                                          -        -                 1,488    1,765
 Adjusted EBITDA                                                              31,620   21,278   49%      70,286   51,168    37%

 

Reconciliation of Revenue to Contribution ex-TAC

 

                                                                Three months ended September 30        Nine months ended

                                                                                                       September 30
                                                                2024         2023         %            2024      2023      %
 ($ in thousands)
 Revenue                                                        90,184       80,094       13%          253,193   236,077   7%
 Cost of revenue (exclusive of depreciation and amortization)   (13,857)     (13,683)                  (43,952)  (44,384)
 Depreciation and amortization attributable to Cost of revenue  (12,018)     (12,727)                  (35,233)  (37,143)
 Gross profit (IFRS)                                            64,309       53,684       20%          174,008   154,550   13%
 Depreciation and amortization attributable to Cost of revenue  12,018       12,727                    35,233    37,143
 Cost of revenue (exclusive of depreciation and amortization)   13,857       13,683                    43,952    44,384
 Performance media cost                                         (4,655)      (3,543)                   (14,854)  (12,418)
 Contribution ex-TAC (Non-IFRS)                                 85,529       76,551       12%          238,339   223,659   7%

 

 

Reconciliation of Net Income (Loss) to Non-IFRS Net Income

 

                                                                Three months ended         Nine months ended

                                                                September 30               September 30
                                                                2024     2023     %              2024        2023          %
 ($ in thousands)
 Net income (loss)                                              14,541   (1,196)  1,316%         10,583      (24,714)      143%
 Acquisition related costs                                      -        171                     -           171
 Amortization of acquired intangibles                           3,851    10,164                  17,950      28,021
 Restructuring                                                  -        -                       -           796
 Stock-based compensation expenses                              2,600    4,214                   8,678       17,783
 Other expenses, net                                            -        -                       1,488       1,765
 Tax effect of non-IFRS adjustments ((1))                       (1,879)  65                      (5,830)     (6,067)
 Non-IFRS Income                                                19,113   13,418   42%            32,869      17,755        85%

 Weighted average shares outstanding-diluted (in millions) (2)  140.4    145.5                   142.4       144.6

 Non-IFRS diluted Earnings Per Share (in USD)                   0.14     0.09     48%            0.23        0.12          88%

 

 

(1) Non-IFRS income includes the estimated tax impact from the expense items
reconciling between net income (loss) and non-IFRS income

(2) Non-IFRS earnings per share is computed using the same weighted-average
number of shares that are used to compute IFRS earnings (loss) per share

 

 

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION

(Unaudited)

 

                                                         September 30         December 31
                                                         2024                 2023
                                                         USD thousands
 Assets
 ASSETS:
 Cash and cash equivalents                               166,535              234,308
 Trade receivables, net                                   201,036             201,973
 Other receivables                                       5,889                8,293
 Current tax assets                                      679                  7,010

 TOTAL CURRENT ASSETS                                    374,139              451,584

 Fixed assets, net                                        16,377              21,401
 Right-of-use assets                                      30,379              31,900
 Intangible assets, net                                   344,604             362,000
 Deferred tax assets                                      18,481              12,393
 Investment in shares                                    25,000               25,000
 Other long-term assets                                  1,092                525

 TOTAL NON-CURRENT ASSETS                                435,933              453,219

 TOTAL ASSETS                                            810,072              904,803

 Liabilities and shareholders' equity

 LIABILITIES:
 Current maturities of lease liabilities                  14,496              12,106
 Trade payables                                           198,559             183,296
 Other payables                                           41,384              29,098
 Current tax liabilities                                 7,043                4,937

 TOTAL CURRENT LIABILITIES                               261,482              229,437

 Employee benefits                                        191                 237
 Long-term lease liabilities                              21,678              24,955
 Long term debt                                           -                   99,072
 Other long-term liabilities                             2,264                6,800
 Deferred tax liabilities                                 562                 754

 TOTAL NON-CURRENT LIABILITIES                           24,695               131,818

 TOTAL LIABILITIES                                       286,177              361,255

 SHAREHOLDERS' EQUITY:
 Share capital                                            389                 417
 Share premium                                            378,815             410,563
 Other comprehensive loss                                (901)                (2,441)
 Retained earnings                                       145,592              135,009

 TOTAL SHAREHOLDERS' EQUITY                              523,895              543,548

 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY              810,072              904,803

 

 

 

 

 CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATION AND OTHER
COMPREHENSIVE INCOME (LOSS)

(Unaudited)

 

                                                                              Nine months ended              Three months ended September 30

                                                                              September 30
                                                                              2024               2023        2024                      2023
                                                                              USD thousands                  USD thousands

 Revenue                                                                      253,193            236,077     90,184                    80,094

 Cost of Revenue (Exclusive of depreciation and                               43,952             44,384      13,857                    13,683

 amortization shown separately below)

  Research and development expenses                                            36,605            39,652       11,693                   12,576
  Selling and marketing expenses                                               84,507            81,556       27,793                   25,580
  General and administrative expenses                                          26,521            38,067       7,821                    11,362
  Depreciation and amortization                                                44,055            57,238      12,758                    20,316
  Other expenses, net                                                         1,488              1,765       -                         -
 Total operating costs                                                         193,176           218,278      60,065                   69,834
                                                                              16,065             (26,585)    16,262                    (3,423)

 Operating profit (loss)

 Financing income                                                              (5,988)           (6,121)      (1,720)                  (1,790)
 Financing expenses                                                           7,842              8,234       1,938                     2,407

 Financing expenses, net                                                      1,854              2,113       218                       617

 Profit (loss) before taxes on income                                         14,211             (28,698)    16,044                    (4,040)

 Tax benefit (expenses)                                                       (3,628)            3,984       (1,503)                   2,844

 Profit (loss) for the period                                                 10,583             (24,714)    14,541                    (1,196)

 Other comprehensive income (loss) items:
 Foreign currency translation differences for foreign operation               1,540              12          1,944                     (1,367)
 Foreign currency translation for subsidiary sold reclassified to profit and  -                  1,234       -                         -
 loss

 Total other comprehensive income (loss)                                      1,540              1,246       1,944                     (1,367)

 Total comprehensive income (loss)                                            12,123             (23,468)    16,485                    (2,563)

 Earnings per share
 Basic earnings (loss) per share (in USD)                                     0.08               (0.17)      0.11                      (0.01)
 Diluted earnings (loss) per share (in USD)                                   0.07               (0.17)      0.10                      (0.01)

 

 

 

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN EQUITY

(Unaudited)

 

                                                          Share capital      Share premium      Other comprehensive income      Retained Earnings      Total
                                                          USD thousands

 Balance as of January 1, 2024                            417                410,563            (2,441)                         135,009                543,548
 Total Comprehensive income for the period
 Profit for the period                                    -                  -                  -                               10,583                 10,583
 Other comprehensive income:
 Foreign currency translation                             -                  -                  1,540                           -                      1,540

 Total comprehensive income for the period                -                  -                  1,540                           10,583                 12,123

 Transactions with owners, recognized directly in equity
 Own shares acquired                                      (37)               (41,647)           -                               -                      (41,684)
 Share based payments                                     -                  9,175              -                               -                      9,175
 Exercise of share options                                9                  724                 -                              -                      733

 Balance as of September 30, 2024                         389                378,815            (901)                           145,592                523,895

 Balance as of January 1, 2023                            413                400,507            (5,801)                         156,496                551,615
 Total Comprehensive income (loss) for the period
 Loss for the period                                      -                  -                  -                               (24,714)               (24,714)
 Other comprehensive income:
 Foreign currency translation                             -                  -                  12                              -                      12
 Foreign currency translation for                         -                  -                  1,234                           -                      1,234

 subsidiary sold

 Total comprehensive income (loss) for the period         -                  -                  1,246                           (24,714)               (23,468)

 Transactions with owners, recognized directly in equity
 Own shares acquired                                      (7)                (8,741)            -                               -                      (8,748)
 Share based payments                                     -                  17,749             -                               -                      17,749
 Exercise of share options                                7                  229                 -                              -                      236

 Balance as of September 30, 2023                         413                409,744            (4,555)                         131,782                537,384

 

 

 

 

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS

(Unaudited)

                                                                   Nine months ended

                                                                    September 30
                                                                   2024               2023
                                                                   USD thousands

 CASH FLOWS FROM OPERATING ACTIVITIES:
 Profit (loss) for the period                                      10,583             (24,714)
 Adjustments for:
 Depreciation and amortization                                      44,055            57,238
 Net financing expense                                             1,581              1,889
 Gain on leases modification                                        (16)              (115)
 Remeasurement of net investment in a finance lease                1,488              -
 Share-based compensation and restricted shares                    8,678              17,783
 Loss on sale of business unit                                     -                  1,765
 Tax expenses (benefit)                                            3,628              (3,984)
             Change in trade and other receivables                 2,306              43,987
 Change in trade and other payables                                 28,549            (68,326)
 Change in employee benefits                                        (44)              7
 Income taxes received                                              553               269
 Income taxes paid                                                  (2,489)           (8,185)
 Interest received                                                  5,002             5,655
 Interest paid                                                      (5,293)           (6,142)
                                                                   98,581             17,127

 Net cash provided by operating activities

 CASH FLOWS FROM INVESTING ACTIVITIES
       Change in pledged deposits, net                             172                1,007
 Payments on finance lease receivable                              1,350              863
 Acquisition of fixed assets                                       (3,870)            (2,933)
 Acquisition and capitalization of intangible assets               (11,867)           (11,387)
 Repayment of debt investment                                      74                 24

 Net cash used in investing activities                             (14,141)           (12,426)

 CASH FLOWS FROM FINANCING ACTIVITIES
       Acquisition of own shares                                   (41,213)           (8,952)
 Proceeds from exercise of share options                           733                236
 Repayment of long-term debt                                       (100,000)          -
 Leases repayment                                                  (11,144)           (12,575)
                                                                   (151,624)          (21,291)

 Net cash used in financing activities

 Net decrease in cash and cash equivalents                         (67,184)           (16,590)

 CASH AND CASH EQUIVALENTS AS OF THE BEGINNING OF PERIOD           234,308            217,500

 EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS              (589)              (1,833)

 CASH AND CASH EQUIVALENTS AS OF THE END OF PERIOD                 166,535            199,077

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  QRTFZLLFZFLBFBB

Recent news on Nexxen International

See all news